Regeneron Pharmaceuticals Inc. (REGN) Share Price - NASDAQ

Regeneron Pharmaceuticals Inc. is traded on the NASDAQ. Regeneron Pharmaceuticals Inc. operates in the Healthcare sector and trades on the NASDAQ under the ticker REGN.

Regeneron Pharmaceuticals Inc. is listed on the NASDAQ, where it trades under the ticker symbol REGN. It is classified in the Healthcare sector.

REGN last traded at USD 831.61 on 4 September 2026, down 1.41% on the session. Live prices for Regeneron Pharmaceuticals Inc. update through the trading day on Wallflake.

Regeneron Pharmaceuticals Inc. has a market capitalisation of approximately USD 85.62B, based on its closing price on 4 September 2026.

Over the past 52 weeks REGN has traded between a low of USD 541.00 and a high of USD 859.34.

Yes. Regeneron Pharmaceuticals Inc. pays a dividend, with a trailing yield of 0.44%. Its payout ratio is approximately 9.01%.

REGN has a price-to-earnings (P/E) ratio of 20.11 and earnings per share (EPS) of USD 41.48. These figures are reported metrics, not a valuation opinion — Wallflake does not issue buy, sell or hold recommendations.

REGN shares are bought and sold through a broker licensed to trade on the NASDAQ. You open an account with a licensed broker, fund it, and place an order quoting the ticker REGN. Wallflake is a market-data and research platform, not a broker, and does not execute trades or give investment advice. See our NASDAQ guide for how the market works. Read the guide